Abstract submission for ISMND 2022 is closed. We thank the submitters and authors for their contributions to the scientific program.

The International Society for Molecular Neurodegeneration (ISMND)

The International Society for Molecular Neurodegeneration (ISMND)  was founded in 2021 with the primary aim to encourage sound scientific advancement, and to effectively foster and inspire new and creative innovations to further accelerating scientific discoveries specifically in the neurodegenerative disease spectrum. By creating a multidisciplinary global platform for researchers from all different facets and levels of scientific disciplines to more readily connect and interact, ISMND strives to enable cutting-edge research and efforts to translate scientific findings into safe and effective therapies, specifically in the area of neurodegenerative diseases.

For more information please visit https://www.ismnd.org 



ISMND 2022 is the first meeting in the former series of International Conference on Molecular Neurodegeneration (ICMN) to be organized by ISMND in collaboration with Molecular Neurodegeneration (https://molecularneurodegeneration.biomedcentral.com/) and with the support of the BrightFocus Foundation (https://www.brightfocus.org/).

Important Dates

Congress Dates: October, 10 - 12, 2022

Abstract Submission Opening: May 3rd, 2022

Abstract Submission Deadline extended until: July 15th, 2022

Follow us on